An ongoing dialogue on HIV/AIDS, infectious diseases,
April 24th, 2009
Colonoscopy in HIV Patients, Part II: Problem (Mostly) Solved
Both here and on the AIDS Clinical Care site, we posted a case of a 50-year-old HIV+ man in need of a screening colonoscopy. What sedation could he receive while on tenofovir/FTC and ritonavir-boosted atazanavir? Specifically, would midazolam and fentanyl (“contraindicated” in the ritonavir package insert) be ok?
(Same issue for efavirenz, by the way.)
We solicited responses from two PharmD’s and a gastroenterologist, and also received a bunch of comments.
The comments vary in specifics, but the most common is similar to this one, echoing what Brian Fennerty wrote:
These sedative drugs are always titrated to effect for individual patients. We are aware that responses are variable and I think it completely unnecessary to alter an HIV patient’s drug regimen to allow them to receive the discussed drugs. In my experience, I have never noticed a marked exaggeration in clinical effects in this scenario anyway. Bolus doses should be reduced and given with more caution, in the same manner that we approach any patient with altered metabolism, such as the elderly, or those known to have hepato-renal failure.
Or said another way, by a clinician receiving ART himself:
As someone who happens to be on efavirenz I received midazolam and fentanyl for a colonoscopy without incident at age 57 two years ago. The dosage used of both medications was comparable with that I have given patients many times for short relatively pain-free procedures before I retired from the practice of anesthesiology Dr. Fennerty’s approach is the one my gastroenterologist used and is one that I endorse. Giving sedation is all about titration according to individual response and circumstances. The additional caveat I have to make is that since the patient could have a prolonged response is to make sure that the recovery personnel are aware of that fact and are prepared to keep the patient under observation for as long as necessary. This might mean scheduling the case earlier in the day so there is no time pressure to discharge the patient.
We may never have complete consensus on this issue, but ultimately this makes the most sense — use the usual drugs, but be aware that there might be a clinically-relevant interaction in some patients.
Categories: Antiretroviral Rounds, HIV, Infectious Diseases, Patient Care
Tags: aids clinical care, anesthesiology, caveat, clinician, drug regimen, efavirenz, gastroenterologist, HIV, hiv patient, metabolism, midazolam, package, PharmD, ritonavir, screening colonoscopy, sedation, sedative drugs, titration
You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.
Comments are closed.

Paul E. Sax, MD
Associate Editor
NEJM Clinician
Biography | Disclosures & Summaries
Learn more about HIV and ID Observations.
Search this Blog
Follow HIV and ID Observations Posts via Email
Archives
Most Popular Posts
- When AI Gets the Medical Advice Wrong — and Right
- How the Z-Pak Took Over Outpatient Medicine
- What Use Is the Physical Examination in Current Medical Practice?
- How the Z-Pak Took Over Outpatient Medicine, Part 2: The Reckoning
- Dengue, Malaria, HIV Cure, and Others — First Cold Snap of the Winter ID Link-o-Rama
-
From the Blog — Most Recent Articles
- Influenza — So Familiar, Still So Mysterious January 14, 2026
- How the Z-Pak Took Over Outpatient Medicine, Part 2: The Reckoning January 6, 2026
- How the Z-Pak Took Over Outpatient Medicine December 29, 2025
- What Use Is the Physical Examination in Current Medical Practice? December 17, 2025
- Dengue, Malaria, HIV Cure, and Others — First Cold Snap of the Winter ID Link-o-Rama December 10, 2025
FROM NEJM — Recent Infectious Disease Articles- Borrelia burgdorferi Infection and Erythema Migrans January 15, 2026Expansion of the range of the lone star tick, a vector for southern tick-associated rash illness, has led to overlap with the range of the Lyme disease vector Ixodes scapularis, which may cause diagnostic uncertainty.
- Case 2-2026: A 63-Year-Old Man with Pulmonary Nodules, Liver Mass, and Vision Loss January 15, 2026A 63-year-old man was admitted to the hospital because of fever, cough, and vision loss in the right eye. He had pulmonary nodules, a liver mass, and multiple brain lesions. A diagnosis was made.
- Primary Palmoplantar Pustulosis January 15, 2026A 60-year-old man with a 30-pack-year smoking history presented with a 2-year history of a painful rash on his palms and soles. Numerous pustules with erosions, crusting, and surrounding erythema were noted.
- The Things We Carry January 15, 2026The ID, the pen, the epinephrine, the scalpel are the nonnegotiables, the necessities for any hospital shift. But they are not the only things a physician carries, and certainly not the most burdensome.
- Serogroup Switching in Neisseria meningitidis with Dual Antibiotic Resistance January 8, 2026Serogroup switching away from serogroup Y has been identified in the major ciprofloxacin-resistant Neisseria meningitidis strain, which may impede identification of ciprofloxacin-resistant cases of N. meningitidis infection.
- Borrelia burgdorferi Infection and Erythema Migrans January 15, 2026
-
Tag Cloud
- Abacavir AIDS antibiotics antiretroviral therapy ART atazanavir baseball Brush with Greatness CDC C diff COVID-19 CROI darunavir dolutegravir elvitegravir etravirine FDA HCV hepatitis C HIV HIV cure HIV testing ID fellowship ID Learning Unit Infectious Diseases influenza Link-o-Rama lyme disease medical education MRSA PEP PrEP prevention primary care raltegravir Really Rapid Review resistance Retrovirus Conference rilpivirine sofosbuvir TDF/FTC tenofovir Thanksgiving vaccines zoster
